Doximity reports revenue of approximately $ 344 million for fiscal year 2022

KinshipThe network of health professionals for the fourth quarter, which ended March 31, recorded revenue of $ 93.7 million, compared to $ 66.7 million last year.

The company had a net profit of $ 36.7 million, up from $ 21.5 million a year earlier. Doximity also released results for its fiscal year 2022, bringing in $ 343.5 million, compared to $ 206.9 million for fiscal year 2021, which ended March 31, 2021. Net income for the year was $ 154.8 million, compared to $ 50.2 million.

For the next quarter, which ends on June 30, Doximity has published a revenue guide from $ 88.6 to $ 89.6 million. For the whole year, which will end on March 31, 2023, it forecasts revenue of $ 454-458 million.

Doximity co-founder and CEO Jeff Tangney said the company had more than two million registered members in the quarter, setting record highs for its fax, e-signature and telemedicine products. It also announced that it has completed the acquisition of the Amion Doctors’ Planning և messaging app in its fourth quarter.

“We have been successful in increasing our workflow package We closed our acquisition of, which provides a schedule for 200,000 US physicians. “When combined with our telemedicine tools used by more than 350,000 unique physicians, NPs and PAs over the past quarter, we believe we will become a cloud of physicians in the United States, a kind of Bloomberg physician,” he said.

Prescription digital therapy company Pear therapy Compared to $ 376,000 in the first quarter of 2021 and $ 1.3 million in the fourth quarter.

Posted by a $ 23.86 million net loss compared to $ 24.39 million in the first quarter of last year. Pear announced more than 9,200 prescriptions for its products in the first quarter, and expects to announce between 50,000 and 60,000 prescriptions for the full year.

“Our momentum from 2021 to 2022 continued with strong revenue and prescription growth in the first quarter,” said Dr. Corey McCann, chief executive officer.

“We continue to expand the availability of our products with advances such as the availability of reSET և reSET-O in Spanish, expansion to new states such as Oklahoma իչ Michigan, ումը CMS recognition through the HCPCS code defining PDT. An important guideline for compensation. We also continue to promote our payer value proposition through 12-month և 24-month health economic data that demonstrates the longevity of clinical outcomes ումը the long-term reduction in the use of health resources. ”

see secret product in Box below

‘The accuracy or reliability of any information/material/calculation contained in this article is not guaranteed. This information has been brought to you by collecting from various mediums / astrologers / almanacs / discourses / beliefs / scriptures. Our purpose is only to deliver information, its users should take it as mere information. In addition, any use thereof shall be the responsibility of the user himself.’

Leave a Reply

Your email address will not be published.

Translate »